logo

FDA Calendar

Share
Company Name Adamas Pharmaceuticals Inc
Drug Name GOCOVRI (sNDA)
Event Name FDA decision on GOCOVRI as treatment for OFF episodes in Parkinson’s disease patients receiving levodopa-based therapy
Event Date 02/01/2021
Outcome Date
Outcome
Drug Status
Rival Drugs
Market Potential
Other Approvals GOCOVRI is already approved for the treatment of levodopa-induced dyskinesia (LID) in patients with Parkinson's disease.
News
Return to FDA Calendar